Skip to content

Clinical trials

Phase 4 Uterine Cervical Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 4 Country / region: China Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20181
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Air Force Military Medical University, China1
GlaxoSmithKline1
Peking Union Medical College Hospital1
Shandong Cancer Hospital and Institute1
Tianjin Medical University Cancer Institute and Hospital1
Xiamen Innovax Biotech Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms6
Uterine Cervical Dysplasia2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Esophageal Neoplasms1
Neoplasms1
Ovarian Neoplasms1
Papillomavirus Infections1
Persistent Infection1
Radiation Injuries1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.